arrow
P

Peter J. Kelly

University College Dublin
H指数:61
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effect of colchicine for secondary prevention according to stroke subtype: A secondary analysis of the CONVINCE randomized trial

根据卒中亚型评估秋水仙碱用于二级预防的效果:CONVINCE随机试验的二次分析

2025-12-020
PRE
Tenecteplase in Central Retinal Artery Occlusion Study (TenCRAOS): Protocol for a randomized-controlled trial

替奈普酶在中央视网膜动脉阻塞研究(TenCRAOS):一项随机对照试验的方案

2025-06-120
PRE
Interleukin-6, C-Reactive Protein, and Recurrence After Stroke: A Time-Course Analysis of Individual-Participant Data
STROKE
IF8.9
2024-12-010
PRE
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trials

秋水仙碱用于缺血性卒中和动脉粥样硬化事件的二级预防: 随机试验的荟萃分析

2024-10-011
OAAI
Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study

edoxaban在房颤患者中的长期有效性和安全性: 来自etna-af-europe研究的4年数据

2024-08-011
OAAI
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial

心房颤动和出血性转化患者缺血性卒中后直接口服抗凝剂的早期与晚期启动: 随机对照ELAN试验的预设子分析

2024-07-022
PRE
Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE) : a randomised controlledtrial

长期秋水仙碱预防非心源性卒中血管复发事件 (convention): 一项随机对照试验

LANCET
IF88.5
2024-07-0111
PRE
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial

替奈普酶与已证实闭塞的轻度缺血性卒中的护理标准 (TEMPO-2): 一项随机,开放标签,3期优越性试验

LANCET
IF88.5
2024-06-0112
PRE
Plasma fibrinogen and risk of vascular recurrence after ischaemic stroke: An individual participant and summary-level data meta-analysis of 11 prospective studies

血浆纤维蛋白原与缺血性卒中后血管复发的风险: 11项前瞻性研究的个体参与者和汇总水平数据荟萃分析

2024-04-101
OA
Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds

他汀类药物在缺血性脑卒中伴脑微出血患者二级预防中的应用

2024-04-093
PRE
C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype

C反应蛋白,Interleukin-6和根据中风亚型的血管复发

2024-01-235
PRE
Symptomatic Carotid Atheroma Inflammation Lumen-stenosis score compared with Oxford and Essen risk scores to predict recurrent stroke in symptomatic carotid stenosis
2023-07-221
OAAI
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation

房颤卒中早期抗凝与晚期抗凝治疗的比较

2023-06-2970
OA
C-Reactive Protein, Interleukin-6, and Vascular Recurrence After Stroke: An Individual Participant Data Meta-Analysis

C反应蛋白、Interleukin-6与卒中后血管复发: 一项个体参与者数据的Meta分析

STROKE
IF8.9
2023-05-0125
OA
Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation
2023-04-1711
OA